Literature DB >> 26348942

RIKEN suspends first clinical trial involving induced pluripotent stem cells.

Ken Garber.   

Abstract

Mesh：

Year:  2015        PMID： 26348942     DOI： 10.1038/nbt0915-890

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  64 in total

1.  The future of iPS cells in advancing regenerative medicine.

Authors:  Peng Liu; K E Li; Shaohua Xu
Journal:  Genet Res (Camb)       Date:  2016-02-11       Impact factor: 1.588

Review 2.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 3.  Drug discovery and development for rare genetic disorders.

Authors:  Wei Sun; Wei Zheng; Anton Simeonov
Journal:  Am J Med Genet A       Date:  2017-07-21       Impact factor: 2.802

4.  Measles vector as a multigene delivery platform facilitating iPSC reprogramming.

Authors:  Qi Wang; Alanna Vossen; Yasuhiro Ikeda; Patricia Devaux
Journal:  Gene Ther       Date:  2019-02-04       Impact factor: 5.250

5.  Creating human germ cells for unmet reproductive needs.

Authors:  Tetsuya Ishii; Renee A Reijo Pera
Journal:  Nat Biotechnol       Date:  2016-05-06       Impact factor: 54.908

6.  Influence of ATM-Mediated DNA Damage Response on Genomic Variation in Human Induced Pluripotent Stem Cells.

Authors:  Junjie Lu; Hu Li; Anna Baccei; Takayo Sasaki; David M Gilbert; Paul H Lerou
Journal:  Stem Cells Dev       Date:  2016-04-11       Impact factor: 3.272

7.  Hematopoietic stem cells meet induced pluripotent stem cells technology.

Authors:  Maria Teresa Esposito
Journal:  Haematologica       Date:  2016-09       Impact factor: 9.941

8.  ZSCAN10 expression corrects the genomic instability of iPSCs from aged donors.

Authors:  Maria Skamagki; Cristina Correia; Percy Yeung; Timour Baslan; Samuel Beck; Cheng Zhang; Christian A Ross; Lam Dang; Zhong Liu; Simona Giunta; Tzu-Pei Chang; Joye Wang; Aparna Ananthanarayanan; Martina Bohndorf; Benedikt Bosbach; James Adjaye; Hironori Funabiki; Jonghwan Kim; Scott Lowe; James J Collins; Chi-Wei Lu; Hu Li; Rui Zhao; Kitai Kim
Journal:  Nat Cell Biol       Date:  2017-08-28       Impact factor: 28.824

Review 9.  Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.

Authors:  Angelos Oikonomopoulos; Tomoya Kitani; Joseph C Wu
Journal:  Mol Ther       Date:  2018-03-06       Impact factor: 11.454

Review 10.  Cell Therapy-a Basic Science Primer for the Sports Medicine Clinician.

Authors:  Bijan Dehghani; Scott Rodeo
Journal:  Curr Rev Musculoskelet Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.